Table 1 Clinical characteristics of patients
| Â | Values (336) |
|---|---|
Gender [No. (%)] | |
 Male | 215(64.0) |
 Female | 121(36.0) |
Age [years] | |
  < =14 | 223(66.4) |
  > 14 | 113(33.6) |
Median (range) | 12 (2–55) |
Body weight(kg)median(range) | 37(10–82) |
Disease [No. (%)] | |
 AML | 110(32.7) |
 ALL | 177(52.7) |
 CML | 16(4.8) |
 MDS | 22(6.5) |
 Others | 11(3.3) |
State of disease [No. (%)] | |
 CR or Chronic phase | 257(76.5) |
 NR or Advanced phase | 79(23.5) |
HLA match (low-resolution) [No. (%)] | |
 4/6 | 113(33.6) |
 5/6 | 168(50.0) |
 6/6 | 55(16.4) |
Conditioning regimen [No. (%)] | |
 Including TBI | 109(32.4) |
 Not including TBI | 227(67.6) |
Total nucleated-cell dose, 107/kg median(range) | 4.17(1.71–13.90) |
Total CD34+ cell dose, 105/kg median(range) | 2.32(0.40–10.55) |